Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 27, 2011, Pages 11211-11216

  Gregory, Sonia M ^a,b   Harada, Erisa ^a,b,c   Liang, Binyong ^a,b   Delos, Sue E ^b   White, Judith M ^b   Tamm, Lukas K ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

Lipid protein interaction; Membrane protein; NMR solution structure; Virus entry

Indexed keywords

DODECYLPHOSPHORYLCHOLINE; GLYCOPROTEIN 2; LIPOSOME; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHA HELIX; ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; EBOLA VIRUS; HUMAN; INTERNAL FUSION LOOP; MEMBRANE FUSION; NUCLEAR MAGNETIC RESONANCE; PH; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; CIRCULAR DICHROISM; EBOLAVIRUS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICELLES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, SECONDARY; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EBOLA VIRUS; FILOVIRIDAE; PRIMATES;

EID: 79960606069     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1104760108     Document Type: Article

References (44)

1. Feldmann H, Geisbert TW (2011) Ebola haemorrhagic fever. Lancet 377:849-862.
2. Hoenen T, Groseth A, Falzarano D, Feldmann H (2006) Ebola virus: Unravelling pathogenesis to combat a deadly disease. Trends Mol Med 12:206-215. (Pubitemid 43728410)
3. Falzarano D, Geisbert TW, Feldmann H (2011) Progress in filovirus vaccine development: Evaluating the potential for clinical use. Expert Rev Vaccines 10:63-77.
4. Geisbert TW, et al. (2010) Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study. Lancet 375:1896-1905.
5. Takada A, et al. (1997) A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA 94:14764-14769. (Pubitemid 28041448)
6. Lee JE, Saphire EO (2009) Ebolavirus glycoprotein structure and mechanism of entry. Future Virol 4:621-635.
7. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. (Pubitemid 40807517)
8. Schornberg K, et al. (2006) Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80:4174-4178.
9. Dube D, et al. (2009) The primed ebolavirus glycoprotein (19-kilodalton GP1,2): Sequence and residues critical for host cell binding. J Virol 83:2883-2891.
10. White JM, Delos SE, Brecher M, Schornberg K (2008) Structures and mechanisms of viral membrane fusion proteins: Multiple variations on a common theme. Crit Rev Biochem Mol Biol 43:189-219. (Pubitemid 351883153)
11. Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15:690-698.
12. Lai AL, Li Y, Tamm LK (2005) Interplay of protein and lipids in virus entry by membrane fusion. Protein-Lipid Interactions, ed Tamm LK (Wiley-VCH, Weinheim, Germany), pp 279-303.
13. Ito H, Watanabe S, Sanchez A, Whitt MA, Kawaoka Y (1999) Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol 73:8907-8912. (Pubitemid 29441763)
14. Lee JE, et al. (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177-182. (Pubitemid 351969896)
15. Weissenhorn W, Carfí A, Lee KH, Skehel JJ, Wiley DC (1998) Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell 2:605-616. (Pubitemid 128379086)
16. Jeffers SA, Sanders DA, Sanchez A (2002) Covalent modifications of the Ebola virus glycoprotein. J Virol 76:12463-12472. (Pubitemid 35386932)
17. Gallaher WR (1996) Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell 85:477-478.
18. Delos SE, White JM (2000) Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein. J Virol 74:9738-9741.
19. Delos SE, et al. (2008) Cysteines flanking the internal fusion peptide are required for the avian sarcoma/leukosis virus glycoprotein to mediate the lipid mixing stage of fusion with high efficiency. J Virol 82:3131-3134. (Pubitemid 351329201)
20. Melder DC, Yin X, Delos SE, Federspiel MJ (2009) A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain. J Virol 83:8575-8586.
21. Malashkevich VN, et al. (1999) Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution. Proc Natl Acad Sci USA 96:2662-2667. (Pubitemid 29148774)
22. Freitas MS, et al. (2007) Structure of the Ebola fusion peptide in a membrane-mimetic environment and the interaction with lipid rafts. J Biol Chem 282:27306-27314. (Pubitemid 47501920)
23. Struck DK, Hoekstra D, Pagano RE (1981) Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20:4093-4099.
24. Koradi R, Billeter M, Wüthrich K (1996) MOLMOL: A program for display and analysis of macromolecular structures. J Mol Graph 14:51-55. (Pubitemid 26152976)
25. Li Z, Blissard GW (2010) Baculovirus GP64 disulfide bonds: The intermolecular disulfide bond of Autographa californica multicapsid nucleopolyhedrovirus GP64 is not essential for membrane fusion and virion budding. J Virol 84:8584-8595.
26. Kielian M (2006) Class II virus membrane fusion proteins. Virology 344:38-47.
27. Han X, Bushweller JH, Cafiso DS, Tamm LK (2001) Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat Struct Biol 8:715-720. (Pubitemid 32757933)
28. Li Y, et al. (2005) Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion. J Virol 79:12065-12076. (Pubitemid 41279323)
29. Lai AL, Tamm LK (2007) Locking the kink in the influenza hemagglutinin fusion domain structure. J Biol Chem 282:23946-23956. (Pubitemid 47328033)
30. Lai AL, Tamm LK (2010) Shallow boomerang-shaped influenza hemagglutinin G13A mutant structure promotes leaky membrane fusion. J Biol Chem 285:37467-37475.
31. Lorieau JL, Louis JM, Bax A (2010) The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface. Proc Natl Acad Sci USA 107:11341-11346.
32. Sainz B, Jr., Rausch JM, Gallaher WR, Garry RF, Wimley WC (2005) Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J Virol 79:7195-7206. (Pubitemid 40677349)
33. Tamm LK, Han X (2000) Viral fusion peptides: A tool set to disrupt and connect biological membranes. Biosci Rep 20:501-518. (Pubitemid 32523208)
34. Barry C, Key T, Haddad R, Duncan R (2010) Features of a spatially constrained cystine loop in the p10 FAST protein ectodomain define a new class of viral fusion peptides. J Biol Chem 285:16424-16433.
35. Modis Y, Ogata S, Clements D, Harrison SC (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427:313-319. (Pubitemid 38133652)
36. Melo MN, et al. (2009) Interaction of the Dengue virus fusion peptide with membranes assessed by NMR: The essential role of the envelope protein Trp101 for membrane fusion. J Mol Biol 392:736-746.
37. Sun X, Belouzard S, Whittaker GR (2008) Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein. J Biol Chem 283:6418-6427.
38. Kadlec J, Loureiro S, Abrescia NG, Stuart DI, Jones IM (2008) The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat Struct Mol Biol 15:1024-1030.
39. Backovic M, Jardetzky TS, Longnecker R (2007) Hydrophobic residues that form putative fusion loops of Epstein-Barr virus glycoprotein B are critical for fusion activity. J Virol 81:9596-9600. (Pubitemid 47311507)
40. Hannah BP, Heldwein EE, Bender FC, Cohen GH, Eisenberg RJ (2007) Mutational evidence of internal fusion loops in herpes simplex virus glycoprotein B. J Virol 81:4858-4865. (Pubitemid 46668682)
41. Stampfer SD, Lou H, Cohen GH, Eisenberg RJ, Heldwein EE (2010) Structural basis of local, pH-dependent conformational changes in glycoprotein B from herpes simplex virus type 1. J Virol 84:12924-12933.
42. Freitas MS, et al. (2011) Measuring the strength of interaction between the Ebola fusion peptide and lipid rafts: Implications for membrane fusion and virus infection. PLoS One 6:e15756.
43. Gómara MJ, Mora P, Mingarro I, Nieva JL (2004) Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein. FEBS Lett 569:261-266. (Pubitemid 38844629)
44. Delos SE, Gilbert JM, White JM (2000) The central proline of an internal viral fusion peptide serves two important roles. J Virol 74:1686-1693. (Pubitemid 30434024)